FIBERLAX owner Contact Information online
from Herbion USA
FIBERLAX
The mark consists of the word mark "FIBERLAX" which is a coined word and is one word with the word "FIBER" written in blue and the word "LAX" written in red coloured font.
US serial number:85094402
Application filling date:Jul. 28, 2010
Register:Principal
Mark type:Trademark
Status:Abandoned because no Statement of Use or Extension Request timely filed after Notice of Allowance was issued. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Status date:Jul. 16, 2012
Publication date:Oct. 19, 2010
Abandoned date:Jul. 16, 2012
Standard character claim:No
Mark drawing type:5 - AN ILLUSTRATION DRAWING WITH WORD(S) /LETTER(S)/ NUMBER(S) INSTYLIZED FORM
Goods and services:For: Dietary supplements for human consumption; Natural herbal supplements; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract
International Class(es): 005- Primary Class
U.
Services:Dietary supplements for human consumption; Natural herbal supplements; Nutritional supplement for eliminating toxins from the body; Nutritional supplement for eliminating toxins from the intestinal tract
Current owner owner name:Herbion USA
Current owner owner address:Suite 100
300 International Drive
Williamsville,
NEW YORK
UNITED STATES
14221
Current owner legal entity type:CORPORATION
Current owner state or country:NEW YORK
Correspondent name address:HERBION USA
HERBION USA
300 INTERNATIONAL DR STE 100
WILLIAMSVILLE,
NEW YORK
UNITED STATES
14221-5783
Correspondent email:ghazal.sajid@herbion.com
Correspondent email authorized:Yes
Trademark staff tm attorney:DONINGER, CHRISTOPHER
Trademark staff law office assigned FIBERLAX:LAW OFFICE 104
Latest trademarks
Popular owners
Glaxo Group Limited (173) Novartis AG (130) JOHNSON & JOHNSON (125) Millennium Pharmaceuticals, Inc. (54) Eli Lilly and Company (51) Windmill Health Products, LLC (46) Bayer Aktiengesellschaft (44) SANOFI (41) Wyeth LLC (41) Pfizer Inc. (39) Forest Laboratories, Inc. (34) Bristol-Myers Squibb Company (33) Vital Health Pharmaceuticals, Inc. (31) Primary Investments Group Limited (28) S. C. Johnson & Son, Inc. (28) MERCK SHARP & DOHME CORP. (27) Futurebiotics, LLC (26) MONSTER ENERGY COMPANY (19) Scott Riddell (17) Biocept, Inc. (16)Popular publication dates
Oct. 19, 2010 Mar. 08, 2011 Mar. 15, 2011 Mar. 22, 2011 Nov. 16, 2010 Mar. 29, 2011 Apr. 19, 2011 Apr. 12, 2011 Oct. 26, 2010 Apr. 26, 2011 Feb. 15, 2011 Oct. 05, 2010 Oct. 12, 2010 Jan. 25, 2011 Sep. 21, 2010 Jan. 11, 2011 Feb. 22, 2011 Nov. 23, 2010 Sep. 28, 2010 Apr. 05, 2011Similar brands
